Which Canadian products are now banned from entering the United States, and when does the ban take effect?

Effective 12:01 a.m. ET on September 29, 2026, Canadian-origin alcoholic beverages, certain dairy products, molasses, non-alcoholic beer, and motorcycle products are barred from formal U.S. entry under Section 338 of the Tariff Act of 1930 — not merely subject to duty. CBP’s CSMS #69851916 guidance confirms most Chapter 98 provisions remain exempt, goods admitted to a foreign-trade zone under privileged foreign status are unaffected, and drawback remains available on the underlying duties, but there is no stated exemption from the entry ban itself. CBP has signaled it may scrutinize shipments for misdeclared origin or classification to prevent circumvention, so confirm now whether any SKU in your catalog falls within the banned HTS lines before routing an entry after September 29.

My company buys specialty pharmaceuticals — does the new Section 232 zero-rate carve-out apply to us?

Possibly. A Federal Register notice published September 23, 2026 sets a 0% Section 232 tariff rate for specialty pharmaceutical categories — orphan-designated drugs, nuclear medicines and radioactive biologics, plasma-derived therapies, fertility drugs, cell and gene therapies, antibody-drug conjugates, CBRN medical countermeasures, and animal health products. The zero rate applies automatically to qualifying products sourced from a list of approved jurisdictions (including the EU, UK, Japan, India, and Vietnam), and takes effect September 29, 2026 for most filers (July 31, 2026 for companies named in Annex III). If your product doesn’t fall within an approved-origin path, submit a request to pharma232@bis.doc.gov documenting the product, its HTSUS classification, country of origin, and the specific U.S. health need it addresses.

When can I expect my IEEPA duty refund from CBP?

CBP’s CAPE system moves into Phase 3 on October 6, 2026, widening the population of entries CBP can process automatically for IEEPA duty refunds. The practical step now is documentation: pull entry summaries, duty-payment records, and the underlying commercial invoices for any entries you believe are eligible so a claim isn’t delayed by missing paperwork once Phase 3 opens the queue.

Is my supply chain now a target of CBP’s new AI enforcement tools?

If your goods move through a third country before reaching the U.S. — or if any link in the chain touches Vietnam, Malaysia, Thailand, Mexico, or Cambodia — the exposure is higher than before. CBP’s AI-driven “detective border” platform, paired with a new National Fraud Detection Center, analyzes routing histories, bills of lading, declared values, and production-capacity data to flag illegal transshipment, country-of-origin fraud, undervaluation, and forced-labor exposure. DOJ’s September memo reinforced this, naming global trade and customs violations a principal enforcement priority backed by False Claims Act exposure — the theory behind this year’s $549.5 million Perfectus Aluminum settlement. Keep contemporaneous, defensible records of where goods are actually made and where value is actually added.

What’s happening in the fourth round of USMCA review talks this week, and how could it affect my Mexico operations?

USTR Jamieson Greer and Mexican Economy Secretary Marcelo Ebrard are holding the fourth formal round of USMCA review negotiations September 28-29, 2026, centered on the 50% Section 232 tariff on steel and aluminum, the 25% tariff on cars and auto parts, and how goods that fail USMCA origin rules should be treated. Mexico is pushing for sector relief; the U.S. is holding a broader tariff increase — reportedly as high as 30% — over the talks as leverage if they stall. No agreement has been announced as of this writing. Maquiladora operators with steel, aluminum, or auto-parts exposure should treat any relief as provisional until a signed text is published.

Does the USMCA’s non-renewal change how my maquiladora should plan for 2027?

Yes, structurally. In July 2026 USTR announced it would not renew USMCA for a new fixed term, instead triggering the agreement’s built-in annual joint-review process — meaning trade terms are now subject to review, and potential renegotiation, every year rather than locked in for a multi-year window. This week’s fourth-round talks are effectively the first substantive test of that new cadence. Treat USMCA preferential treatment as something to be reconfirmed annually, and build sourcing and structural flexibility — including bonded and FTZ (foreign-trade zone) options that don’t depend on a specific tariff outcome — into 2027 planning now.

If I route goods through Mexico, could CBP treat that as transshipment under the new enforcement push?

CBP’s “detective border” enforcement platform explicitly lists Mexico among the routing points it is watching for illegal transshipment of Chinese-origin goods, alongside Vietnam, Malaysia, Thailand, and Cambodia. That doesn’t put legitimate maquiladora production at risk, but it raises the documentation bar. Vietnam’s president said this month, in a comparable position, “we do not tolerate the transshipment of goods” and committed to proving products are actually manufactured domestically — a useful marker for the standard CBP is now applying broadly. Keep clean, contemporaneous records establishing substantial transformation and USMCA-qualifying origin: bills of materials, production records, and rules-of-origin certifications that can be produced quickly if a shipment is questioned.

Does the Trump-Xi $30 billion tariff deal reduce costs for goods my maquiladora imports from China for further processing?

Only narrowly, and probably not for the categories most maquiladoras handle. Following the September 24-26, 2026 summit, the U.S. and China agreed to cut tariffs on a defined $30 billion slice of “non-sensitive” trade — China lowering duties on U.S. agricultural goods, seafood, wood products, cosmetics, and medical devices, and the U.S. cutting tariffs on Chinese-made small appliances, toys, holiday decorations, and children’s car seats. Rare-earth and critical-mineral export licensing — the issue with the most direct bearing on electronics and industrial manufacturing inputs — remains unresolved. Don’t assume broad tariff relief on industrial inputs from this deal until specific product lines are confirmed.